CD133+/Musashi-I+/CD34- neural stem cells in gliomas of different grades

被引：0
|
作者：
Thon, N. [1 ]
Grau, S. [1 ]
Krebs, B. [1 ]
Kretzschmar, H. [1 ]
Tonn, J. [1 ]
Goldbrunner, R. [1 ]
机构：
[1] Univ Munich, Munich, Germany
来源：
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE | 2006年 / 24卷 / 08期
关键词：
tumorprogression; stem cell; isolation; CD133; Musashi-I;
D O I：
10.1016/j.ijdevneu.2006.09.140
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：529 / 529
页数：1
相关论文
共 50 条
  • [31] CD 133 (AC 133) expression on different kinds of CD 34+peripheral blood stem cells.
    Viarengo, G
    Perotti, C
    Bernuzzi, S
    Del Fante, C
    Bergamaschi, P
    Bellotti, L
    Maliardi, V
    Salvaneschi, L
    BLOOD, 2001, 98 (11) : 121B - 121B
  • [32] CD34- stem cells as the earliest precursors of hematopoietic progeny
    Huss, R
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (11) : 1022 - 1023
  • [33] Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells
    Hemmoranta, Heidi
    Hautaniemi, Sampsa
    Niemi, Jari
    Nicorici, Daniel
    Laine, Jarmo
    Yli-Harja, Olli
    Partanen, Jukka
    Jaatinen, Taina
    STEM CELLS AND DEVELOPMENT, 2006, 15 (06) : 839 - 851
  • [34] Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells
    He, XH
    Gonzalez, V
    Tsang, A
    Thompson, J
    Tsang, TC
    Harris, DT
    STEM CELLS AND DEVELOPMENT, 2005, 14 (02) : 188 - 198
  • [35] CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells
    Kobari, L
    Giarratana, MC
    Pflumio, F
    Izac, B
    Coulombel, L
    Douay, L
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (02): : 273 - 281
  • [36] miR-34C Disrupts the Stemness of Purified CD133+ Prostatic Cancer Stem Cells
    Chen, Yuan
    Rao, Qun
    Zhang, Huiping
    Xu, Hua
    Zhang, Cuntai
    Zhuang, Qianyuan
    Ye, Zhangqun
    UROLOGY, 2016, 96 : 177.e1 - 177.e9
  • [37] Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+ CD133+ Stem Cells in Patients With Type 2 Diabetes
    Fadini, Gian Paolo
    Rigato, Mauro
    Cappellari, Roberta
    Bonora, Benedetta Maria
    Avogaro, Angelo
    DIABETES CARE, 2017, 40 (01) : 125 - 131
  • [38] Transcriptional Profiles of CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
    Lottaz, Claudio
    Beier, Dagmar
    Meyer, Katharina
    Kumar, Praveen
    Hermann, Andreas
    Schwarz, Johannes
    Junker, Markus
    Oefner, Peter J.
    Bogdahn, Ulrich
    Wischhusen, Joerg
    Spang, Rainer
    Storch, Alexander
    Beier, Christoph P.
    CANCER RESEARCH, 2010, 70 (05) : 2030 - 2040
  • [39] Differential gene expression of cord blood-derived CD34+ and CD133+ cells
    Hemmoranta, H.
    Hautaniemi, S.
    Niemi, J.
    Nicorici, D.
    Laine, J.
    Yli-Harja, O.
    Partanen, J.
    Jaatinen, T.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 70 - 70
  • [40] CD133+ pluripotent stem cells for the treatment of chronic liver failure
    Lemoli, R.
    Catani, L.
    Lorenzini, S.
    Giordano, R.
    Motta, M. R.
    Giudice, V.
    Sollazzo, D.
    Nicolini, B.
    Montelatici, E.
    Andriolo, G.
    Dan, E.
    Massari, E.
    Baccarani, M.
    Bernardi, M.
    Losinno, F.
    Andreone, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S304 - S304
12345